Prior Immunogenicity to Anti-TNF Biologics Is Not Associated With More Anti-Drug Antibodies to Vedolizumab or Ustekinumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Digestive Diseases and Sciences
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prior Immunogenicity to Anti-TNF Biologics Is Not Associated With Increased Anti-Drug Antibodies to Vedolizumab or Ustekinumab
Dig. Dis. Sci. 2021 May 21;[EPub Ahead of Print], NJ Costable, ZA Borman, J Ji, MC Dubinsky, RC UngaroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.